Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population

被引:60
作者
Ruiz, A
Antiñolo, G
Fernández, RM
Eng, C
Marcos, I
Borrego, S
机构
[1] Hosp Univ Virgen del Rocio, Unidad Genet med & Diagnost Prenatal, Seville 41013, Spain
[2] Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA
[3] Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA
[4] Ohio State Univ, Div Human Genet, Columbus, OH 43210 USA
[5] Univ Cambridge, Canc Res Campaign, Human Canc Genet Res Grp, Cambridge, England
关键词
D O I
10.1046/j.1365-2265.2001.01328.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The molecular basis of sporadic medullary thyroid carcinoma (MTC) remains elusive. While germline gain-of-function mutations in the RET protooncogene cause hereditary MTC, somatic activating RET mutations and loss of heterozygosity of markers in various chromosomal regions representing deletions of tumour suppressor genes, have been described in a variable number of sporadic MTC. A previous report suggested that the presence of a germline variant at RET codon 836 (S836S) was associated with the development of sporadic MTC and, furthermore, that the presence of S836S was highly correlated with somatic RET M918T mutation in the MTC. Thus, we sought to determine if the S836S variant would be associated with sporadic MTC from a completely different population base, that of Andalucia. Design This is a case-control study to determine whether the presence of RET germline S836S is correlated with sporadic MTC in Andalucia. Patients Thirty-two patients with sporadic MTC from the Andalucia region of Spain, serviced by our University Hospital, were ascertained throughout the period 1995-99. Sporadic MTC was defined as a lack of personal or family history suggestive of multiple endocrine neoplasia type 2 (MEN 2) and lack of germline RET mutations which define any MEN 2 subtype. A region and race matched cohort of 250 controls was also obtained. Measurements The frequency of the S836S allele was determined in cases and controls and compared using the standard chi-squared statistic and Fisher's exact test. Results The polymorphic allele frequency at codon 836 in the control population (18/500 chromosomes, 3.6%) differed significantly from the MTC case cohort, 9.3% of case chromosomes (six of 64 alleles, Fisher's exact test, two-tailed, P=0.043). Conclusions Germline RET S836S variant is associated with a two- to three-fold risk of sporadic MTC in the Spanish population, in accordance with a previous study based on German cases. Our observations suggest that this phenomenon might be universal and not limited to Germany.
引用
收藏
页码:399 / 402
页数:4
相关论文
共 13 条
[1]   Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease [J].
Borrego, S ;
Eng, C ;
Sánchez, B ;
Sáez, ME ;
Navarro, E ;
Antiñolo, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09) :3361-3364
[2]   Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression [J].
Borrego, S ;
Sáez, ME ;
Ruiz, A ;
Gimm, O ;
López-Alonso, M ;
Antiñolo, G ;
Eng, C .
JOURNAL OF MEDICAL GENETICS, 1999, 36 (10) :771-774
[3]   RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease [J].
Borrego, S ;
Ruiz, A ;
Saez, ME ;
Gimm, O ;
Gao, X ;
López-Alonso, M ;
Hernández, A ;
Wright, FA ;
Antiñolo, G ;
Eng, C .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (08) :572-578
[4]  
DRACAPOLI NH, 1994, CURRENT PROTOCOLS HU, V1
[5]  
Eng C, 1996, CANCER RES, V56, P2167
[6]   RET proto-oncogene in the development of human cancer [J].
Eng, C .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :380-393
[7]   MUTATION OF THE RET PROTOONCOGENE IN SPORADIC MEDULLARY-THYROID CARCINOMA [J].
ENG, C ;
MULLIGAN, LM ;
SMITH, DP ;
HEALEY, CS ;
FRILLING, A ;
RAUE, F ;
NEUMANN, HPH ;
PFRAGNER, R ;
BEHMEL, A ;
LORENZO, MJ ;
STONEHOUSE, TJ ;
PONDER, MA ;
PONDER, BAJ .
GENES CHROMOSOMES & CANCER, 1995, 12 (03) :209-212
[8]   The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis [J].
Eng, C ;
Clayton, D ;
Schuffenecker, I ;
Lenoir, G ;
Cote, G ;
Gagel, RF ;
vanAmstel, HKP ;
Lips, CJM ;
Nishisho, I ;
Takai, SI ;
Marsh, DJ ;
Robinson, BG ;
FrankRaue, K ;
Raue, F ;
Xue, FY ;
Noll, WW ;
Romei, C ;
Pacini, F ;
Fink, M ;
Niederle, B ;
Zedenius, J ;
Nordenskjold, M ;
Komminoth, P ;
Hendy, GN ;
Gharib, H ;
Thibodeau, SN ;
Lacroix, A ;
Frilling, A ;
Ponder, BAJ ;
Mulligan, LM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19) :1575-1579
[9]   Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease [J].
Fitze, G ;
Schreiber, M ;
Kuhlisch, E ;
Schackert, HK ;
Roesner, D .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (05) :1469-1473
[10]   Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation [J].
Gimm, O ;
Neuberg, DS ;
Marsh, DJ ;
Dahia, PLM ;
Cuong, HV ;
Raue, F ;
Hinze, R ;
Dralle, H ;
Eng, C .
ONCOGENE, 1999, 18 (06) :1369-1373